NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV (NAMS) Covered Calls
As of September 29, 2026, NAMS has 27 covered call opportunities in the coming three months. Return ranges from 11.8 to 176.8% until expiration. Annualized return ranges from 36.5 to 268.5%. The nearest expiration is October 16, 2026. Maximum potential profit is $3,992.
Read more
Running NAMS covered calls helps you generate consistent income from NewAmsterdam Pharma Company NV's shares you already own, turning a long stock position into a yield-producing asset. A covered call on NewAmsterdam Pharma Company NV involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best NAMS covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if NAMS stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling NAMS covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given NewAmsterdam Pharma Company NV covered call is worth writing.
NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, focuses on improving patient care in populations with metabolic diseases. Its lead investigational candidate, obicetrapib, is a novel, selective inhibitor that targets the Cholesteryl Ester Transfer Protein (CETP), which has been clinically shown to reduce low-density lipoprotein cholesterol (LDL-C) while at the same time substantially increase high-density lipoprotein cholesterol (HDL-C). The company was founded in 2019 and is based in Naarden, the Netherlands.
Income-focused investors, long-term NAMS holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling NAMS covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best NewAmsterdam Pharma Company NV covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile18.85% Subdued
- Market cap (M$)2,846
- 52 weeks high-43.58%
- 52 weeks low13.27%
- Analyst recommendationStrong Buy
1.12 - Target price$51.80
117.56% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-04
- P/E—
- Future P/E—
- EPS (ttm)-2.18
- EPS growth next 5 years37.44%
As of September 29, 2026
| 2027-02-19 | 147 | 45.00 | 99.29 | 2.00 | 5.70 | 2442.00 | 108.15 | 268.53 | -8.86 | +0.40 | 38 | 3.70 |
| 2027-02-19 | 147 | 40.00 | 77.15 | 2.75 | 6.50 | 2017.00 | 89.33 | 221.80 | -12.18 | +0.46 | 4,000 | 3.75 |
| 2026-11-20 | 56 | 30.00 | 32.86 | 0.15 | 0.65 | 757.00 | 33.53 | 218.51 | -0.66 | +0.15 | 1,174 | 0.50 |
| 2026-10-16 | 21 | 25.00 | 10.72 | 0.25 | 0.55 | 267.00 | 11.82 | 205.52 | -1.11 | +0.24 | 384 | 0.30 |
| 2027-01-15 | 112 | 35.00 | 55.00 | 0.40 | 3.50 | 1282.00 | 56.78 | 185.03 | -1.77 | +0.31 | 417 | 3.10 |
| 2027-02-19 | 147 | 35.00 | 55.00 | 3.60 | 7.50 | 1602.00 | 70.95 | 176.16 | -15.94 | +0.52 | 916 | 3.90 |
| 2028-01-21 | 483 | 60.00 | 165.72 | 2.50 | 7.50 | 3992.00 | 176.79 | 133.60 | -11.07 | +0.44 | 45 | 5.00 |
| 2027-02-19 | 147 | 30.00 | 32.86 | 4.70 | 8.50 | 1212.00 | 53.68 | 133.28 | -20.81 | +0.58 | 4,123 | 3.80 |
| 2027-04-16 | 203 | 35.00 | 55.00 | 3.80 | 8.00 | 1622.00 | 71.83 | 129.16 | -16.83 | +0.53 | 0 | 4.20 |
| 2027-01-15 | 112 | 30.00 | 32.86 | 0.85 | 4.80 | 827.00 | 36.63 | 119.36 | -3.76 | +0.42 | 13 | 3.95 |
As of September 29, 2026
Sell covered calls with the data behind you
Find the best NAMS covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→